ETCTN A Phase 1/2 Study of M3814 (peposertib) in Combination with Hypofractionated Radiotherapy for the Treatment of Locally Advanced Pancreatic Adenocarcinoma Adult CIRB - Early Phase Emphasis Active Available to Open